LeadIQ logo
Learn more at LeadIQ.com

Insights

Executive Leadership Expansion Ensoma has recently appointed key executives like Jim Burns, Kouki Harasaki, and Dr. Stella to leadership positions, signaling potential strategic shifts and growth opportunities that could be leveraged for collaborative sales endeavors.

Financial Health & Growth With substantial recent financing amounting to $85 million, Ensoma's financial strength positions them well for expansion and innovation, creating opportunities for sales professionals to engage with a company poised for growth.

Cutting-edge Gene Editing Expertise By hiring top talent such as Dr. Stella as Vice President of Gene Editing, Ensoma showcases a focus on cutting-edge technology and expertise, presenting an entry point for sales professionals to engage in discussions around innovative solutions.

Specialized Biotechnology Research Ensoma's specialization in one-time in vivo treatments targeting blood and immune cells for curing diseases presents a unique niche that sales professionals can cater to by highlighting specific solutions tailored to this focus area.

Strategic Partnerships & Acquisitions Partnerships with entities like Arix Bioscience and acquisitions of companies like Twelve Bio demonstrate Ensoma's strategic growth approach, opening avenues for sales professionals to explore collaborative opportunities and unique value propositions for potential customers.

Similar companies to Ensoma

Ensoma Tech Stack

Ensoma uses 8 technology products and services including Google Font API, Google Cloud, jQuery Migrate, and more. Explore Ensoma's tech stack below.

  • Google Font API
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • jQuery Migrate
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • Microsoft
    Miscellaneous
  • Microsoft Azure
    Platform As A Service
  • PHP
    Programming Languages
  • Nginx
    Web Servers

Media & News

Ensoma's Email Address Formats

Ensoma uses at least 1 format(s):
Ensoma Email FormatsExamplePercentage
FLast@ensoma.comJDoe@ensoma.com
92%
FirstLast@ensoma.comJohnDoe@ensoma.com
6%
LastFirst@ensoma.comDoeJohn@ensoma.com
1%
LFirst@ensoma.comDJohn@ensoma.com
1%

Frequently Asked Questions

Where is Ensoma's headquarters located?

Minus sign iconPlus sign icon
Ensoma's main headquarters is located at Boston, MA US. The company has employees across 2 continents, including North AmericaEurope.

What is Ensoma's official website and social media links?

Minus sign iconPlus sign icon
Ensoma's official website is ensoma.com and has social profiles on LinkedIn.

How much revenue does Ensoma generate?

Minus sign iconPlus sign icon
As of October 2024, Ensoma's annual revenue reached $15M.

What is Ensoma's SIC code NAICS code?

Minus sign iconPlus sign icon
Ensoma's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ensoma have currently?

Minus sign iconPlus sign icon
As of October 2024, Ensoma has approximately 122 employees across 2 continents, including North AmericaEurope. Key team members include Chief Technology Officer: D. L.Chief Scientific Officer: R. P.Vice President Finance: J. D.. Explore Ensoma's employee directory with LeadIQ.

What industry does Ensoma belong to?

Minus sign iconPlus sign icon
Ensoma operates in the Biotechnology Research industry.

What technology does Ensoma use?

Minus sign iconPlus sign icon
Ensoma's tech stack includes Google Font APIGoogle CloudjQuery MigrateOpen GraphMicrosoftMicrosoft AzurePHPNginx.

What is Ensoma's email format?

Minus sign iconPlus sign icon
Ensoma's email format typically follows the pattern of . Find more Ensoma email formats with LeadIQ.

How much funding has Ensoma raised to date?

Minus sign iconPlus sign icon
As of October 2024, Ensoma has raised $50M in funding. The last funding round occurred on May 16, 2023 for $50M.
Ensoma

Ensoma

Biotechnology ResearchMassachusetts, United States51-200 Employees

Ensoma /en’sōmə/ is derived from the Greek phrase “en soma,” meaning in the body. We develop one-time in vivo treatments that precisely engineer any or all blood and immune cells to cure diseases from within. We have a bigger, bolder vision for genomic medicine: treatments as versatile, precise, and far-reaching as the body’s own cells. Our team takes inspired action towards pushing beyond today’s possible with the goal of delivering a one-time, off-the-shelf treatment to patients everywhere.

Section iconCompany Overview

Headquarters
Boston, MA US
Website
ensoma.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $50M

    Ensoma has raised a total of $50M of funding over 3 rounds. Their latest funding round was raised on May 16, 2023 in the amount of $50M.

  • $10M$50M

    Ensoma's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $50M

    Ensoma has raised a total of $50M of funding over 3 rounds. Their latest funding round was raised on May 16, 2023 in the amount of $50M.

  • $10M$50M

    Ensoma's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.